Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus, Tacrolimus, and Thymoglobulin for GVHD Prophylaxis
NCT00589563Phase 2Completed
- Sponsor
- City of Hope
- Start
- May 2007
- Primary completion
- Feb 2012
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus, tacrolimus + Wuzhi capsule, antithymocyte globulin in graft-versus-host disease (GVHD), sponsored by City of Hope. Started May 2007; status: completed.
02
Drugs
sirolimustacrolimus + Wuzhi capsuleantithymocyte globulin
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00589563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00589563.